XML 32 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Note 12 - Long-term Incentive Plan
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
12.
Long-Term Incentive Plan
 
On
August 12, 2009,
the Board of Directors of Avalon approved the renewal of the expired
1998
Long-term Incentive Plan which provides for the granting of options which are intended to be non-qualified stock options (“NQSO’s”) for federal income tax purposes except for those options designated as incentive stock options (“ISO’s”) which qualify under Section
422
of the Internal Revenue Code. The name of the plan was changed to the
2009
Long-term Incentive Plan (“the Option Plan”) to reflect the year of approval. On
October 6, 2009,
at a Special Meeting of Shareholders, the shareholders approved the Option Plan. Avalon has reserved
1,300,000
shares of Class A Common Stock for issuance to employees and non-employee directors. NQSO’s
may
be granted with an exercise price which is
not
less than
100%
of the fair market value of the Class A Common Stock on the date of grant. Options designated as ISO’s shall
not
be less than
110%
of fair market value for employees who are
ten
percent shareholders and
not
less than
100%
of fair market value for other employees. The Board of Directors
may,
from time to time in its discretion, grant options to
one
or more outside directors, subject to such terms and conditions as the Board of Directors
may
determine, provided that such terms and conditions are
not
inconsistent with other applicable provisions of the Option Plan. Options shall have a term of
no
longer than
ten
years from the date of grant; except that for an option designated as an ISO which is granted to a
ten
percent shareholder, the option shall have a term
no
longer than
five
years.
 
No
option shall be exercisable prior to
one
year after its grant, unless otherwise provided by the Option Committee of the Board of Directors (but in
no
event before
6
months after its grant), and thereafter options shall become exercisable in installments, if any, as provided by the Option Committee. Options must be exercised for full shares of common stock. To the extent that options are
not
exercised when they become initially exercisable, they shall be carried forward and be exercisable until the expiration of the term of such options.
No
option
may
be exercised by an optionee after his or her termination of employment for any reason with Avalon or an affiliate, except in certain situations provided by the Option Plan.
 
The purpose of the Avalon Holdings Corporation
2009
Long-term Incentive Plan (the “Plan”) is (a) to improve individual employee performance by providing long-term incentives and rewards to employees of Avalon, (b) to assist Avalon in attracting, retaining and motivating employees and non-employee directors with experience and ability, and (c) to associate the interests of such employees and directors with those of the Avalon shareholders. Under the Plan,
1,300,000
shares have been reserved for the issuance of stock options of which
688,000
options were outstanding at
December 31, 2018.
In
November 2018,
72,000
of the options granted were exercised.
 
The stock options, vest ratably over a
five
year period and have a contractual term of
ten
years from the date of grant. At the end of each contractual vesting period, the share price of the Avalon common stock, traded on a public stock exchange (NYSE Amex), must reach a predetermined price within
three
years following such contractual vesting period before the stock options are exercisable (See table below). If the Avalon common stock price does
not
reach the predetermined price, the stock options will either be cancelled or the period will be extended at the discretion of the Board of Directors. In
2018
and
2017,
the Board of Directors extended the period of time for certain vested options that were
not
exercisable due to those options
not
meeting the predetermined stock price within the
three
years following the contractual vesting period.
 
The grant-date fair values of the stock option awards were estimated using the Monte Carlo Simulation. The Monte Carlo Simulation was selected to determine the fair value because it incorporates
six
minimum considerations;
1
) the exercise price of the option,
2
) the expected term of the option, taking into account both the contractual term of the option, the effects of employees’ expected exercise and post-vesting employment termination behavior, as well as the possibility of change in control events during the contractual term of the option agreements,
3
) the current fair value of the underlying equity,
4
) the expected volatility of the value of the underlying share for the expected term of the option,
5
) the expected dividends on the underlying share for the expected term of the option and
6
) the risk-free interest rate(s) for the expected term of the option.
 
The grant date fair value of the underlying equity was determined to be equal to Avalon’s publicly traded stock price as of the grant dates times the sum of the Class A and Class B common shares outstanding.
 
The expected term, or time until the option is exercised, is typically based on historical exercising behavior of previous option holders of a company’s stock.  Due to the fact that the Company has had
no
historical exercising activity, prior to
2018,
the simplified method was applied.  Because of the nature of the vesting described above, the options are separated into
five
blocks, with each block having its own vesting period and expected term. 
 
For stock option awards, the expected volatility was based on the observed historical volatility of Avalon common stock. There were
no
expected dividends and the risk-free interest rate was based on yield data for U. S. Treasury securities over a period consistent with the expected term.
 
The following table is a summary of the stock option activity during
2018
and
2017:
                    
 
   
 
 
 
 
Weighted
   
Weighted
   
 
 
 
   
Number of
   
Average
   
Average
   
Aggregate
 
   
Options
   
Exercise
   
Fair Value at
   
Intrinsic
 
   
Granted
   
Price
   
Grant Date
   
Value
 
Outstanding at January 1, 2017
   
760,000
    $
2.51
    $
1.00
     
 
 
Options granted
   
-
     
-
     
-
     
 
 
Options exercised
   
-
     
-
     
-
     
 
 
Options cancelled or forfeited
   
-
     
-
     
-
     
 
 
Outstanding at December 31, 2017
   
760,000
     
2.51
     
1.00
     
 
 
Options granted
   
-
     
-
     
-
     
 
 
Options exercised
   
(72,000
)    
2.37
     
0.92
     
 
 
Options cancelled or forfeited
   
-
     
-
     
-
     
 
 
Outstanding at December 31, 2018
   
688,000
    $
2.52
    $
1.00
    $
89,760
 
Options Vested
   
634,000
    $
2.58
    $
1.05
    $
45,480
 
Exercisable at December 31, 2018
   
634,000
    $
2.58
    $
1.05
    $
45,480
 
 
The stock options vest and become exercisable based upon achieving
two
critical metrics as follows:
 
 
1
)
Contract Vesting Term: The stock options vest ratably over a
five
year period.
 
2
)
The Avalon common stock price traded on a public stock exchange (NYSE Amex) must reach the predetermined vesting price within
three
years after the options become vested under the contractual vesting term.
 
The table below represents the period and predetermined stock price needed for vesting.
 
 
Begins
 
Ends
 
Predetermined
 
 
Vesting
 
Vesting
 
Vesting Price
 
Block 1
12 months after Grant Dates
 
48 months after Grant Dates
  $
3.43
 
Block 2
24 months after Grant Dates
 
60 months after Grant Dates
  $
4.69
 
Block 3
36 months after Grant Dates
 
72 months after Grant Dates
  $
6.43
 
Block 4
48 months after Grant Dates
 
84 months after Grant Dates
  $
8.81
 
Block 5
60 months after Grant Dates
 
96 months after Grant Dates
  $
12.07
 
 
In
2018,
the predetermined stock price was reached for exercising all vested options that have previously met the time vesting requirement.
 
The total intrinsic value of the
72,000
options exercised during the year ended
December 31, 2018
was
$154,000.
 
Compensation costs were approximately
$6,000
and
$12,000
for the years ended
December 31, 2018
and
2017,
respectively, based upon the estimated grant date fair value calculations. As of
December 31, 2018,
there was approximately
$23,000
of total unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of
5.42
years.